Skip to main content
. 2019 Nov 20;156(2):151–157. doi: 10.1001/jamadermatol.2019.3595

Figure 2. Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Levels in Psoriasis and Controls and Psoriasis Severity.

Figure 2.

A, sLOX-1 levels (pg/mL) are increased in psoriasis when compared with age- and sex-matched controls. The horizontal line in the middle of each box indicates the median, while the top and bottom borders of the box mark the 75th and 25th percentiles, respectively. The whiskers above and below the box mark the 90th and 10th percentiles. The points beyond the whiskers indicate outliers. B, sLOX-1 levels (pg/mL) are positively associated with Psoriasis Area Severity Index (PASI) score independent of traditional risk factors (β = 0.20; 95% CI, 0.047-0.350; P = .01). The blue dots indicate predicted value, and the shaded area indicates the 95% CI.